Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.(HiSCO 06)
Phase 2
Recruiting
- Conditions
- Patients with synchronous or metachronous liver metastasis from gastric cancer
- Registration Number
- JPRN-UMIN000024004
- Lead Sponsor
- Hiroshima Surgical Study group of Clinical Oncology (HiSCO)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Stage IV gastric cancer patients with peritoneal dissemination, or positive cytology para aolta LN netastasis. Patients whom doctors consider unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method